ArticleScientific reports2022

Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19.

Vincenzo Messina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.